Welcome Guest
Home > Clinical Breast Cancer > Volume 3 |  Issue 5

Table of Contents

Volume 3 |  Issue 5

Publication Date: December 2002
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
301		 Local Control of Breast Cancer: Issues and Answers
George W. Sledge, Jr
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
302-306		 Highlights From: 27th European Society of Medical Oncology Congress, Nice, France, October 18-22
Heather DeGrendele, Kavita Maung, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Researches in Brief
Page Number of this Article in the Print Version
309-311		 Recent Studies with Anastrozole Versus Tamoxifen in the Management of Breast Cancer
Angelia D. Gibson, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
312-314		 Optimizing the Efficacy of Trastuzumab: An Update of Research Efforts
David Lee, Vinay K. Jain
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
315-322		 Will We Need Lymph Node Dissection at All in the Future?
Robert L. J. H. Bourez, Emiel J. Th. Rutgers, Cornelius J. H. Van de Velde
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
323-325		 To Dissect or Not To Dissect?—That Is the Question
Douglas Reintgen, Solange Pendas, Rosemary Giuliano, Gray Swor, Andrew Pippas, James Jakub
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
326-332		 Adjuvant Use of Taxanes for Patients with Breast Cancer: We See the Tip of the Iceberg
Clifford Hudis
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
333-340		 Phase II Trial of Doxorubicin/Docetaxel/Cyclophosphamide for Locally Advanced and Metastatic Breast Cancer: Results from NSABP Trial BP-58
Roy E. Smith, Stewart J. Anderson, Ann Brown, Aaron P. Scholnik, Ajit M. Desai, Carl G. Kardinal, Barry C. Lembersky, Eleftherios P. Mamounas
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
341-345		 Microtubule-Associated Parameters as Predictive Markers of Docetaxel Activity in Advanced Breast Cancer Patients: Results of a Pilot Study
Chantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, Fatima Cardoso, Arlette Fellous, David Gancberg, Marie-Christine Bissery, Marianne Paesmans, Denis Larsimont, Martine J. Piccart, Angelo Di Leo
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
346-352		 Weekly Docetaxel/Paclitaxel in Pretreated Metastatic Breast Cancer
Alessandra Gennari, Valentina Guarneri, Elisabetta Landucci, Cinzia Orlandini, Marianna Rondini, Barbara Salvadori, Sergio Ricci, Pier Franco Conte
  • Abstract
  • No Access
  • Add to Cart
Letter to the Editor
Page Number of this Article in the Print Version
353-354		 Toward Re-expressing Tumor Suppressor Gene Maspin in Breast Cancer
Ming Zhang
  • Abstract
  • No Access
  • Add to Cart